For: |
Dai LC, Wang X, Yao X, Lu YL, Ping JL, He JF. Antisense oligonucleotide targeting midkine suppresses |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i8/1208.htm |
Number | Citing Articles |
1 |
Yoshifumi Takei, Kenji Kadomatsu. Midkine: From Embryogenesis to Pathogenesis and Therapy. 2012; : 225 doi: 10.1007/978-94-007-4234-5_20
|
2 |
Li Cheng Dai, Xing Yao, Jing Zhong. Midkine: From Embryogenesis to Pathogenesis and Therapy. 2012; : 273 doi: 10.1007/978-94-007-4234-5_24
|
3 |
Kenji Kadomatsu, Péter Bencsik, Anikó Görbe, Csaba Csonka, Kazuma Sakamoto, Satoshi Kishida, Péter Ferdinandy. Therapeutic potential of midkine in cardiovascular disease. British Journal of Pharmacology 2014; 171(4): 936 doi: 10.1111/bph.12537
|
4 |
Arezoo Gowhari Shabgah, Fatemeh Ezzatifar, Surendar Aravindhan, Angelina Olegovna Zekiy, Majid Ahmadi, Seyed Mohammad Gheibihayat, Jamshid Gholizadeh Navashenaq. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy. IUBMB Life 2021; 73(4): 659 doi: 10.1002/iub.2458
|
5 |
Panagiota S. Filippou, George S. Karagiannis, Anastasia Constantinidou. Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target. Oncogene 2020; 39(10): 2040 doi: 10.1038/s41388-019-1124-8
|
6 |
Lingjuan Huang, Xianggui Wang, Shiyao Pei, Xin Li, Liang Dong, Xiaohui Bian, Hongyin Sun, Liping Jin, Huihui Hou, Wensheng Shi, Xiyuan Zhang, Lining Zhang, Shuang Zhao, Xiang Chen, Mingzhu Yin. Single-Cell Profiling Reveals Sustained Immune Infiltration, Surveillance, and Tumor Heterogeneity in Infiltrative Basal Cell Carcinoma. Journal of Investigative Dermatology 2023; 143(11): 2283 doi: 10.1016/j.jid.2023.04.020
|
7 |
Marina Majaj, Ludwig T. Weckbach. Midkine—A novel player in cardiovascular diseases. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.1003104
|
8 |
J. Zhong, L. C. Dai. Targeting Liposomal Nanomedicine to Cancer Therapy. Technology in Cancer Research & Treatment 2012; 11(5): 475 doi: 10.7785/tcrt.2012.500259
|
9 |
Qiang Yan, Hui-Lian Huang, Xing Yao, Jing Li, Li-Qin Li, Jing Zhong, Li-Shan Min, Li-Cheng Dai, Shu-Sen Zheng. Novel functional proteins interact with midkine in hepatic cancer cells. Hepatobiliary & Pancreatic Diseases International 2012; 11(3): 272 doi: 10.1016/S1499-3872(12)60160-X
|
10 |
Li-Cheng Dai. Midkine translocated to nucleoli and involved in carcinogenesis. World Journal of Gastroenterology 2009; 15(4): 412-416 doi: 10.3748/wjg.15.412
|
11 |
Keiko Nakanishi, Yoshihito Tokita, Sachiko Aono, Michiru Ida, Fumiko Matsui, Yujiro Higashi, Atsuhiko Oohira. Neuroglycan C, A Brain-Specific Chondroitin Sulfate Proteoglycan, Interacts with Pleiotrophin, A Heparin-Binding Growth Factor. Neurochemical Research 2010; 35(8): 1131 doi: 10.1007/s11064-010-0164-9
|
12 |
LI LI QIN, HUI LIAN HUANG, JIN LIANG PING, WEI XU, JING LI, LI CHENG DAI. Expression of midkine and endoglin in breast carcinomas with different immunohistochemical profiles. APMIS 2011; 119(2): 103 doi: 10.1111/j.1600-0463.2010.02699.x
|
13 |
Emily Ross-Munro, Faith Kwa, Jenny Kreiner, Madhavi Khore, Suzanne L. Miller, Mary Tolcos, Bobbi Fleiss, David W. Walker. Midkine: The Who, What, Where, and When of a Promising Neurotrophic Therapy for Perinatal Brain Injury. Frontiers in Neurology 2020; 11 doi: 10.3389/fneur.2020.568814
|
14 |
Sachiko Seki, Mutsunori Fujiwara, Masaaki Matsuura, Shuichi Fujita, Hisazumi Ikeda, Izumi Asahina, Tohru Ikeda. Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors. Oral Oncology 2011; 47(7): 588 doi: 10.1016/j.oraloncology.2011.04.013
|
15 |
Ludwig T. Weckbach, Leopold Groesser, Julia Borgolte, Judith-Irina Pagel, Frank Pogoda, Jürgen Schymeinsky, Josef Müller-Höcker, Mehdi Shakibaei, Takashi Muramatsu, Elisabeth Deindl, Barbara Walzog. Midkine acts as proangiogenic cytokine in hypoxia-induced angiogenesis. American Journal of Physiology-Heart and Circulatory Physiology 2012; 303(4): H429 doi: 10.1152/ajpheart.00934.2011
|
16 |
|